Sharing cutlery, plates or cups, because HIV cannot be transmitted in saliva. Social contact with people with HIV, because HIV is not transmitted by touch or through the air. Through animal bites, ...

Twice-a-year shot to prevent HIV could stop transmission — if people can get it Tests found that new drug nearly eliminated new infections. By The Associated Press. Wire Service.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear ...

Share on Pinterest A CDC report highlights the potential risks of HIV transmission through injectable cosmetic services like “vampire facials.” Visoot Uthairam/Getty Images An investigation ...

A review of data from thousands of people in 25 countries finds that people taking HIV medicine have "almost zero risk" of spreading the virus via sex once their levels are low.

Reducing schistosomiasis infections is a cost-effective way of also cutting HIV transmission in Sub-Saharan Africa, say researchers. Skip to content Bringing science & development together through ...

Transmission of HIV-1 via intercellular connections has been estimated as 100–1000 times more efficient than a cell-free process, perhaps in part explaining persistent viral spread in the ...

More than a quarter of Scots surveyed failed to identify all of the main transmission routes of HIV. There are now between 4,500 and 5,500 people living with HIV in Scotland. The figures come in the ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking studies, Gilead Sciences’ shot, a drug named lenacapavir, nearly ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking studies, Gilead Sciences’ shot, a drug named lenacapavir, nearly ...